Literature DB >> 25910226

Histogram Analysis of Amide Proton Transfer Imaging to Identify Contrast-enhancing Low-Grade Brain Tumor That Mimics High-Grade Tumor: Increased Accuracy of MR Perfusion.

Ji Eun Park1, Ho Sung Kim1, Kye Jin Park1, Choong Gon Choi1, Sang Joon Kim1.   

Abstract

PURPOSE: To determine whether histogram analysis of amide proton transfer (APT) imaging provides increased accuracy of magnetic resonance (MR) perfusion imaging for the identification of contrast material-enhancing low-grade tumor (World Health Organization grades 1 and 2) that mimics high-grade tumor (World Health Organization grades 3 and 4).
MATERIALS AND METHODS: This retrospective study was approved by the institutional review board. Forty-five patients with pathologically proven, solitary, contrast-enhancing tumors were enrolled in this study. APT-derived signal intensity from the calculated APT asymmetry at the offset frequency of 3.5 ppm and normalized cerebral blood volume (nCBV) were measured on solid portions of the tumor by using a 90% histogram cutoff (denoted as APT90 and nCBV90, respectively). The diagnostic performance of the imaging parameters was determined with leave-one-out cross validation. Interobserver agreement was assessed by using the intraclass correlation coefficient.
RESULTS: APT90 demonstrated a significant difference between contrast-enhancing low-grade and high-grade tumors for both readers (P < .001 for both readers). Compared with nCBV90, adding APT90 significantly improved the area under the receiver operating characteristic curve (AUC) for the identification of contrast-enhancing low-grade tumor from 0.80 to 0.97 for reader 1 (P = .023) and from 0.82 to 0.97 for reader 2 (P = .035), respectively. By using leave-one-out cross-validation, the cross-validated AUC of the combination of nCBV90 and APT90 was 0.95 for reader 1 and 0.96 for reader 2. The intraclass correlation coefficient for the APT90 calculations was 0.89.
CONCLUSION: Histogram analysis of APT imaging provided increased accuracy of MR perfusion imaging for the identification of contrast-enhancing low-grade tumor that mimics high-grade tumor. (©) RSNA, 2015 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25910226     DOI: 10.1148/radiol.2015142347

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

Review 1.  The Applicability of Amide Proton Transfer Imaging in the Nervous System: Focus on Hypoxic-Ischemic Encephalopathy in the Neonate.

Authors:  Yang Zheng; Xiaoming Wang
Journal:  Cell Mol Neurobiol       Date:  2017-09-23       Impact factor: 5.046

Review 2.  Radiomics as a Quantitative Imaging Biomarker: Practical Considerations and the Current Standpoint in Neuro-oncologic Studies.

Authors:  Ji Eun Park; Ho Sung Kim
Journal:  Nucl Med Mol Imaging       Date:  2018-02-01

Review 3.  Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies.

Authors:  Weiqiang Dou; Chien-Yuan Eddy Lin; Hongyuan Ding; Yong Shen; Carol Dou; Long Qian; Baohong Wen; Bing Wu
Journal:  Quant Imaging Med Surg       Date:  2019-10

4.  Endogenous Chemical Exchange Saturation Transfer MRI for the Diagnosis and Therapy Response Assessment of Brain Tumors: A Systematic Review.

Authors:  Sachi Okuchi; Ahmed Hammam; Xavier Golay; Mina Kim; Stefanie Thust
Journal:  Radiol Imaging Cancer       Date:  2020-01-31

5.  Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.

Authors:  Yoon Seong Choi; Sung Soo Ahn; Seung-Koo Lee; Jong Hee Chang; Seok-Gu Kang; Se Hoon Kim; Jinyuan Zhou
Journal:  Eur Radiol       Date:  2017-01-23       Impact factor: 5.315

Review 6.  Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum.

Authors:  Peter C M van Zijl; Wilfred W Lam; Jiadi Xu; Linda Knutsson; Greg J Stanisz
Journal:  Neuroimage       Date:  2017-04-21       Impact factor: 6.556

7.  Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Yoshihiko Fukukura; Hirofumi Hirano; Yuko Goto; Masashi Sasaki; Yuta Akamine; Jochen Keupp; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

8.  Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.

Authors:  Ji Eun Park; Ji Ye Lee; Ho Sung Kim; Joo-Young Oh; Seung Chai Jung; Sang Joon Kim; Jochen Keupp; Minyoung Oh; Jae Seung Kim
Journal:  Eur Radiol       Date:  2018-02-27       Impact factor: 5.315

9.  Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma.

Authors:  Kye Jin Park; Ho Sung Kim; Ji Eun Park; Woo Hyun Shim; Sang Joon Kim; Seth A Smith
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315

10.  Amide proton transfer-weighted MRI in distinguishing high- and low-grade gliomas: a systematic review and meta-analysis.

Authors:  Chong Hyun Suh; Ji Eun Park; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim; Ho Sung Kim
Journal:  Neuroradiology       Date:  2019-01-21       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.